Drug Profile
Hinokitiol/hydrocortisone acetate/ethyl aminobenzoate - AYUMI Pharma
Alternative Names: Hinoporon; Hinoporon oral ointmentLatest Information Update: 29 May 2018
Price :
$50
*
At a glance
- Originator Showa Yakuhin Kako
- Developer AYUMI Pharma
- Class Monoterpenes
- Mechanism of Action Glucocorticoid receptor agonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Periodontal disorders